Pharsight Monthly Summary
NOVEMBER, 2022
Recent happenings in patent protected drugs.
spacer_11
At a Glance
36
drug patents lapsed
Photos
81
new drug patents introduced
Reviews
spacer_11
Companies who recently launched drugs
 
 
AADI SUB
 
ABBVIE
 
AM REGENT
 
AVEO PHARMS
 
AXSOME
 
AZURITY
 
BIOXCEL
 
CMP DEV LLC
 
DAIICHI SANKYO INC
 
EXELA PHARMA
 
GILEAD SCIENCES INC
 
GLOBAL BLOOD THERAPS
 
GUERBET
 
MAIA PHARMS INC
 
MAYNE PHARMA
 
MIRUM
 
MITSUBISHI TANABE
 
NEXUS
 
NOVO
 
OTSUKA
 
PACIRA PHARMS INC
 
PROVEPHARM SAS
 
SEAGEN
 
SPIL
 
TEVA BRANDED PHARM
 
TEVA PHARM
 
VERITY
 
VIATRIS
 
 
spacer_11
Drugs not protected by their main patents
Drug Company
ABILIFY OTSUKA
ABILIFY MYCITE KIT OTSUKA
ADASUVE ALEXZA PHARMS
ADDYI SPROUT PHARMS
ADLYXIN SANOFI-AVENTIS US
AGGRASTAT MEDICURE
ARNUITY ELLIPTA GLAXOSMITHKLINE
AXUMIN BLUE EARTH
CLEVIPREX CHIESI
COPAXONE TEVA PHARMS USA
DALIRESP ASTRAZENECA
DEXILANT TAKEDA PHARMS USA
EMEND MSD MERCK CO
EPIVIR VIIV HLTHCARE
FERAHEME COVIS
FLONASE SENSIMIST ALLERGY RELIEF HALEON US HOLDINGS
GADAVIST BAYER HLTHCARE
GILENYA NOVARTIS
GLEEVEC NOVARTIS
IRESSA ASTRAZENECA
JADENU SPRINKLE NOVARTIS
JUXTAPID CHIESI
LEVEMIR FLEXTOUCH NOVO NORDISK INC
LIPTRUZET ORGANON
LUMASON BRACCO
LYRICA CR UPJOHN
MACRILEN NOVO
NEXIUM 24HR ASTRAZENECA LP
NORDITROPIN FLEXPRO NOVO NORDISK INC
NOVOLOG FLEXTOUCH NOVO NORDISK INC
NOXAFIL MERCK SHARP DOHME
ORBACTIV MELINTA THERAP
REYATAZ BRISTOL MYERS SQUIBB
SAXENDA NOVO
SELZENTRY VIIV HLTHCARE
SOLIQUA 100/33 SANOFI-AVENTIS US
SOMAVERT PHARMACIA
SPIRIVA RESPIMAT BOEHRINGER INGELHEIM
SYNRIBO TEVA PHARMS INTL
TORISEL PF PRISM CV
TRUVADA GILEAD
VASCEPA AMARIN PHARMS
VELPHORO VIFOR FRESENIUS
VIIBRYD ABBVIE
XTORO FONSECA BIOSCIENCES
ZYVOX PFIZER
Drug patents lapsed
Drug Patent Patent expiry
AFREZZA 8215300 Nov, 2022
AFREZZA 8215300 Nov, 2022
AFREZZA 8215300 Nov, 2022
AMITIZA 8097653 Nov, 2022
AMITIZA 8389542 Nov, 2022
AMLODIPINE BESYLATE 6828339 Nov, 2022
AMLODIPINE BESYLATE 6828339 Nov, 2022
AMLODIPINE BESYLATE 6828339 Nov, 2022
BANZEL 6740669 Nov, 2022
BANZEL 6740669 Nov, 2022
BANZEL 6740669 Nov, 2022
BANZEL 6740669 Nov, 2022
CHANTIX 6890927*PED Nov, 2022
CHANTIX 6890927*PED Nov, 2022
HORIZANT 8048917 Nov, 2022
HORIZANT 8048917 Nov, 2022
INBRIJA 7384649 Nov, 2022
NEURONTIN 7256216*PED Nov, 2022
OCALIVA 7138390 Nov, 2022
OCALIVA 7138390 Nov, 2022
OSPHENA 9566252 Nov, 2022
PROMACTA 7160870 Nov, 2022
PROMACTA 7160870 Nov, 2022
PROMACTA 7160870 Nov, 2022
PROMACTA 7160870 Nov, 2022
PROMACTA 7160870 Nov, 2022
PROMACTA KIT 7160870 Nov, 2022
PROMACTA KIT 7160870 Nov, 2022
SELZENTRY 7368460 Nov, 2022
SELZENTRY 7368460 Nov, 2022
SELZENTRY 7368460 Nov, 2022
SELZENTRY 7368460 Nov, 2022
SELZENTRY 7368460 Nov, 2022
SUMAVEL DOSEPRO 8241244 Nov, 2022
SUMAVEL DOSEPRO 8491524 Nov, 2022
VEREGEN 10434059 Nov, 2022
Newly introduced Drug Patents
Drug Patent Patent expiry
ABILIFY MYCITE KIT 11464423 Sep, 2030
ABILIFY MYCITE KIT 11476952 Apr, 2026
AIRDUO DIGIHALER 11464923 Jun, 2040
ARMONAIR DIGIHALER 11464923 Jun, 2040
ASPRUZYO SPRINKLE 11510878 Jan, 2038
AUVELITY 11478468 Nov, 2034
AUVELITY 11497721 Nov, 2034
AUVELITY 11510918 Nov, 2034
BLUDIGO 11499050 Dec, 2037
CAROSPIR 11491166 Oct, 2036
ELCYS 11510941 Jan, 2039
ELCYS 11510942 Jan, 2039
ELUCIREM 10973934 Aug, 2039
ELUCIREM 8114863 Sep, 2028
EMERPHED 11478436 May, 2040
EXPAREL 11452691 Jan, 2041
FOTIVDA 11504365 Nov, 2039
FYARRO 11497737 Oct, 2040
IGALMI 11478422 Jun, 2039
IGALMI 11497711 Jun, 2039
IGALMI 11517524 Jun, 2039
IMVEXXY 11497709 Nov, 2032
INJECTAFER 11478502 Jan, 2027
LIVMARLI 11497745 Feb, 2040
MAVYRET 11484534 Mar, 2034
MAVYRET 11484534*PED Sep, 2034
NYMALIZE 11517563 Apr, 2038
ORIAHNN (COPACKAGED) 11459305 Nov, 2028
OXBRYTA 10017491 Dec, 2032
OXBRYTA 10034879 Dec, 2032
OXBRYTA 10493035 Oct, 2037
OXBRYTA 10722502 Feb, 2035
OXBRYTA 10806733 Dec, 2032
OXBRYTA 11020382 Dec, 2036
OXBRYTA 9018210 Nov, 2033
OXBRYTA 9248199 Jan, 2034
OXBRYTA 9447071 Feb, 2035
OZEMPIC 10220155 Jul, 2026
OZEMPIC 10335462 Jun, 2033
OZEMPIC 10357616 Jan, 2026
OZEMPIC 10376652 Jan, 2026
OZEMPIC 11097063 Jul, 2026
OZEMPIC 11311679 Jan, 2026
OZEMPIC 11446443 Oct, 2025
OZEMPIC 7762994 May, 2024
OZEMPIC 8114833 Aug, 2025
OZEMPIC 8129343 Dec, 2031
OZEMPIC 8536122 Mar, 2026
OZEMPIC 8579869 Jun, 2023
OZEMPIC 8684969 Oct, 2025
OZEMPIC 8920383 Jul, 2026
OZEMPIC 9108002 Jan, 2026
OZEMPIC 9132239 Feb, 2032
OZEMPIC 9457154 Sep, 2027
OZEMPIC 9616180 Jan, 2026
OZEMPIC 9687611 Feb, 2027
OZEMPIC 9775953 Jul, 2026
OZEMPIC 9861757 Jan, 2026
OZEMPIC RE46363 Aug, 2026
PROAIR DIGIHALER 11464923 Jun, 2040
RADICAVA ORS 11478450 Nov, 2039
SINCALIDE 11110063 Apr, 2038
SINCALIDE 11318100 Apr, 2038
TLANDO 11464735 Apr, 2041
TOBI PODHALER 11484671 Nov, 2024
TUKYSA 11504370 Mar, 2033
TURALIO 10189833 May, 2036
TURALIO 10435404 Jul, 2038
TURALIO 10730876 May, 2036
TURALIO 10941142 Jul, 2038
TURALIO 10961240 Jul, 2038
TURALIO 7893075 May, 2033
TURALIO 8404700 Nov, 2027
TURALIO 8461169 Apr, 2028
TURALIO 8722702 Nov, 2027
TURALIO 9169250 Nov, 2027
TURALIO 9358235 Jun, 2033
TURALIO 9802932 May, 2036
VEKLURY 11491169 May, 2041
VEKLURY 11492353 Dec, 2031
VIBERZI 11484527 Mar, 2033
What's new on Pharsight!

Find the answers you need on Drugs.

Are you looking for accurate and reliable information on drugs and generics? Look no further! Our FAQ page is packed with answers to some of the most commonly asked questions about drugs. Visit and bookmark our FAQ page today!

Bonus - Don't see your question answered there? Contact us, and we'll be happy to help!

Check out FAQ page

Shoot first, and win big! Figure out the drugs that are about to enter the NCE-1 period to stay ahead of your generic launch strategy!

Want to be first-to-market with your generic drugs? Stay ahead of the game with our exclusive list of drugs facing patent challenges updated every month.

Check out NCE-1 period list

spacer_11

Our insights are consumed by 1000+ leading pharma companies

© 2022 GreyB Research